• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于雄甾-16-烯-3-醇框架的甾体钌(II)和铱(III)配合物的合成、表征和生物学性质。

Synthesis, Characterization, and Biological Properties of Steroidal Ruthenium(II) and Iridium(III) Complexes Based on the Androst-16-en-3-ol Framework.

机构信息

Institute of Organic Chemistry (IOC) , Karlsruhe Institute of Technology (KIT) , Fritz-Haber-Weg 6 , 76131 Karlsruhe , Germany.

Institute of Functional Interfaces (IFG) , Karlsruhe Institute of Technology (KIT) , Hermann von Helmholtz Platz 1 , 76344 Eggenstein-Leopoldshafen , Germany.

出版信息

Inorg Chem. 2019 Dec 2;58(23):15917-15926. doi: 10.1021/acs.inorgchem.9b02402. Epub 2019 Nov 12.

DOI:10.1021/acs.inorgchem.9b02402
PMID:31714764
Abstract

A range of novel cyclometalated ruthenium(II) and iridium(III) complexes with a steroidal backbone based on androsterone were synthesized and characterized by NMR spectroscopy and X-ray crystallography. Their cytotoxic properties in RT112 and RT112 cP (cisplatin-resistant) cell lines as well as in MCF7 and somatic fibroblasts were compared with those of the corresponding nonsteroidal complexes and the noncyclometalated pyridyl complexes as well as with cisplatin as reference. All steroidal complexes were more active in RT112 cP cells than cisplatin, whereby the cyclometalated pyridinylphenyl complexes based on showed high cytotoxicity while maintaining low resistant factors of 0.33 and 0.50.

摘要

合成了一系列基于雄甾酮的新型甾体骨架的钉(II)和铱(III)配合物,并通过 NMR 光谱和 X 射线晶体学进行了表征。将它们在 RT112 和 RT112 cP(顺铂耐药)细胞系以及 MCF7 和体成纤维细胞中的细胞毒性与相应的非甾体配合物以及非环金属化的吡啶基配合物以及顺铂进行了比较。所有甾体配合物在 RT112 cP 细胞中的活性均高于顺铂,其中基于的钉的环金属化吡啶基苯基配合物具有很高的细胞毒性,同时保持低耐药因子 0.33 和 0.50。

相似文献

1
Synthesis, Characterization, and Biological Properties of Steroidal Ruthenium(II) and Iridium(III) Complexes Based on the Androst-16-en-3-ol Framework.基于雄甾-16-烯-3-醇框架的甾体钌(II)和铱(III)配合物的合成、表征和生物学性质。
Inorg Chem. 2019 Dec 2;58(23):15917-15926. doi: 10.1021/acs.inorgchem.9b02402. Epub 2019 Nov 12.
2
Half-Sandwich Iridium(III) and Ruthenium(II) Complexes Containing P^P-Chelating Ligands: A New Class of Potent Anticancer Agents with Unusual Redox Features.含P^P螯合配体的半夹心铱(III)和钌(II)配合物:一类具有异常氧化还原特性的新型强效抗癌剂。
Inorg Chem. 2018 Feb 19;57(4):1705-1716. doi: 10.1021/acs.inorgchem.7b01959. Epub 2018 Feb 5.
3
Highly potent half-sandwich iridium and ruthenium complexes as lysosome-targeted imaging and anticancer agents.高活性半三明治型铱和钌配合物作为溶酶体靶向成像和抗癌试剂。
Dalton Trans. 2018 Nov 13;47(44):15772-15782. doi: 10.1039/c8dt02963f.
4
Hetero-Bis-Conjugation of Bioactive Molecules to Half-Sandwich Ruthenium(II) and Iridium(III) Complexes Provides Synergic Effects in Cancer Cell Cytotoxicity.生物活性分子与半三明治型钌(II)和铱(III)配合物的异双共轭在癌细胞毒性方面产生协同效应。
Inorg Chem. 2021 Jul 5;60(13):9529-9541. doi: 10.1021/acs.inorgchem.1c00641. Epub 2021 Jun 22.
5
Biological Potential of Halfsandwich Ruthenium(II) and Iridium (III) Complexes.半夹心钌(II)和铱(III)配合物的生物活性
Anticancer Agents Med Chem. 2016;16(11):1455-1460. doi: 10.2174/1871520615666151029100749.
6
Rhodamine-modified fluorescent half-sandwich iridium and ruthenium complexes: potential application as bioimaging and anticancer agents.罗丹明修饰的荧光半夹心铱和钌配合物:作为生物成像和抗癌剂的潜在应用。
Dalton Trans. 2019 Apr 9;48(15):4788-4793. doi: 10.1039/c9dt00999j.
7
Antitumor Effects of Ir(III)-2-Indazole Complexes for Triple Negative Breast Cancer.三阴性乳腺癌中铱(III)-2-吲唑配合物的抗肿瘤作用。
Inorg Chem. 2021 Dec 6;60(23):17593-17607. doi: 10.1021/acs.inorgchem.1c02193. Epub 2021 Nov 12.
8
Novel C,N-Cyclometalated Benzimidazole Ruthenium(II) and Iridium(III) Complexes as Antitumor and Antiangiogenic Agents: A Structure-Activity Relationship Study.新型C,N-环金属化苯并咪唑钌(II)和铱(III)配合物作为抗肿瘤和抗血管生成剂:构效关系研究
J Med Chem. 2015 Sep 24;58(18):7310-27. doi: 10.1021/acs.jmedchem.5b01194. Epub 2015 Sep 4.
9
Similarities and differences in d low-spin ruthenium, rhodium and iridium half-sandwich complexes: synthesis, structure, cytotoxicity and interaction with biological targets.低自旋钌、铑和铱半夹心配合物的相似性和差异性:合成、结构、细胞毒性及与生物靶标的相互作用。
J Biol Inorg Chem. 2019 Jun;24(4):591-606. doi: 10.1007/s00775-019-01665-2. Epub 2019 May 21.
10
Insights into the anticancer photodynamic activity of Ir(III) and Ru(II) polypyridyl complexes bearing β-carboline ligands.β-咔啉配体的 Ir(III)和 Ru(II) 多吡啶配合物的抗癌光动力活性研究进展。
Eur J Med Chem. 2024 Oct 5;276:116618. doi: 10.1016/j.ejmech.2024.116618. Epub 2024 Jun 28.

引用本文的文献

1
Cyclometalated complexes: promising metallodrugs in the battle against cancer.环金属化配合物:抗癌斗争中颇具潜力的金属药物。
RSC Med Chem. 2025 Jul 31. doi: 10.1039/d5md00178a.
2
Synthesis, biological activities, and future perspectives of steroidal monocyclic pyridines.甾体单环吡啶的合成、生物活性及未来展望
RSC Med Chem. 2023 Sep 7;14(10):1934-1972. doi: 10.1039/d3md00411b. eCollection 2023 Oct 18.